Key result
Novel HTRA1 deletion links to early-onset stroke, recurrent TIAs, and premature dementia.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Case report identifies a novel heterozygous HTRA1 deletion in a young adult, revealing early-onset stroke and dementia linked to hereditary cerebral small vessel disease.
Biallelic mutations in the high-temperature requirement A serine peptidase 1 (HTRA1) gene are known to cause an extremely rare cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), which belongs to the group of hereditary cerebral small vessel diseases and is mainly observed in the Japanese population. Even though this pathology is inherited in an autosomal recessive manner, recent studies have described symptomatic carriers with heterozygous HTRA1 mutations who have milder symptoms than patients with biallelic HTRA1 mutations. We present the case of a Lithuanian male patient who had a stroke at the age of 36, experienced several transient ischemic attacks, and developed an early onset, progressing dementia. These clinical symptoms were associated with extensive leukoencephalopathy, lacunar infarcts, and microbleeds based on brain magnetic resonance imaging (MRI). A novel heterozygous in-frame HTRA1 gene deletion (NM_002775.5:c.533_535del; NP_002766.1:p.(Lys178del)) was identified by next generation sequencing. The variant was consistent with the patient's phenotype, which could not be explained by alternative causes, appeared highly deleterious after in silico analysis, and was not reported in the medical literature or population databases to date.
No takes yet. Share an insight, caveat, or question.
Grigaitė et al. (2021) conducted a case report in Cerebral small vessel disease with young-onset stroke and progressive dementia associated with heterozygous HTRA1 mutation (n=1). Heterozygous in-frame HTRA1 gene deletion (NM_002775.5:c.533_535del; p.(Lys178del)) was evaluated on Clinical and neuroimaging phenotype of stroke, transient ischemic attacks, early-onset progressive dementia, leukoencephalopathy, lacunar infarcts, and microbleeds. A novel heterozygous in-frame HTRA1 deletion (c.533_535del) was identified in 1 male patient presenting with stroke at age 36, TIAs, and early-onset dementia.
Synapse has enriched 10 related papers. Consider them for comparative context: